FDA Inspection 1085701 — Centaur Inc

Centaur Inc — FEI 1931750

The FDA completed an inspection of Centaur Inc on January 18, 2019 in Olathe, KS. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Veterinary.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
January 18, 2019
Fiscal Year
2019
Product Type
Veterinary
Project Area
Monitoring of Marketed Animal Drugs, Feed, and Devices
Location
Olathe, KS (United States)